Marketplace
As its homeland market, ATB has always kept Thailand as its priority market. ATB has recently aimed to in-license new chemical and biotechnology entities (NCEs & NBEs) and the second-brand oncology and hematology products, including cancer supportive care and to locally develop its own Thai new chemical entities, in responding to the current market dynamic towards the trend of aging society.
Due to an implementation of ASEAN Economic Community (AEC), the boundary between each ASEAN countries becomes invisible. In 2016, ATB has consequently set up its footprint in oversea market by establishing its representative office (ATBVN) in Ho Chi Minh city, Vietnam. Currently, ATBVN has operated its business, starting from osteoporosis product, covering both Hanoi and Ho Chi Minh cities.
As new frontier market, ATB has also decided to proceed its investment in Myanmar. With the on-going regulatory affairs progression, ATBMM is expected to establish early 2019.